These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 24648158

  • 1. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
    Ahmed TA, Ibrahim HM, Samy AM, Kaseem A, Nutan MT, Hussain MD.
    AAPS PharmSciTech; 2014 Jun; 15(3):772-80. PubMed ID: 24648158
    [Abstract] [Full Text] [Related]

  • 2. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H, Bodmeier R.
    Int J Pharm; 2007 Mar 06; 332(1-2):107-14. PubMed ID: 17084049
    [Abstract] [Full Text] [Related]

  • 3. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
    Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Kaseem A, Nutan MT, Hussain MD.
    J Pharm Sci; 2012 Oct 06; 101(10):3753-62. PubMed ID: 22753324
    [Abstract] [Full Text] [Related]

  • 4. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H, Bodmeier R.
    Eur J Pharm Sci; 2008 Jul 03; 34(2-3):164-72. PubMed ID: 18501569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release.
    Parent M, Nouvel C, Koerber M, Sapin A, Maincent P, Boudier A.
    J Control Release; 2013 Nov 28; 172(1):292-304. PubMed ID: 24001947
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH, Liang ZH, Zeng S.
    Int J Pharm; 2007 Jun 07; 337(1-2):102-8. PubMed ID: 17296274
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y, Jensen H, Petersen NJ, Larsen SW, Østergaard J.
    J Pharm Biomed Anal; 2018 Feb 20; 150():95-106. PubMed ID: 29216591
    [Abstract] [Full Text] [Related]

  • 14. Sustained-release delivery of octreotide from biodegradable polymeric microspheres.
    Rhee YS, Sohn M, Woo BH, Thanoo BC, DeLuca PP, Mansour HM.
    AAPS PharmSciTech; 2011 Dec 20; 12(4):1293-301. PubMed ID: 21948321
    [Abstract] [Full Text] [Related]

  • 15. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer.
    Brodbeck KJ, DesNoyer JR, McHugh AJ.
    J Control Release; 1999 Dec 06; 62(3):333-44. PubMed ID: 10528071
    [Abstract] [Full Text] [Related]

  • 16. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
    Desai KG, Mallery SR, Schwendeman SP.
    Eur J Pharm Biopharm; 2008 Sep 06; 70(1):187-98. PubMed ID: 18472254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In-situ forming PLGA implants: Towards less toxic solvents.
    Ramos F, Willart JF, Neut C, Agossa K, Siepmann J, Siepmann F.
    Int J Pharm; 2024 May 25; 657():124121. PubMed ID: 38621617
    [Abstract] [Full Text] [Related]

  • 19. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
    Elkharraz K, Ahmed AR, Dashevsky A, Bodmeier R.
    Int J Pharm; 2011 May 16; 409(1-2):89-95. PubMed ID: 21356287
    [Abstract] [Full Text] [Related]

  • 20. Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems.
    Liu H, Venkatraman SS.
    J Pharm Sci; 2012 May 16; 101(5):1783-93. PubMed ID: 22318766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.